Buprenorphine And Naloxone Tablet
Product Images NDC 63629-9483

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 63629-9483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

HCI stands for Human-Computer Interaction, which refers to the design, development, and evaluation of computer systems that people interact with. This field focuses on creating interfaces that are intuitive and user-friendly, allowing for easy navigation and efficient completion of tasks. It involves studying how individuals interact with technology, identifying their needs and preferences, and designing interfaces to meet those needs. HCI is a multidisciplinary field that draws on a range of disciplines including computer science, psychology, design, and engineering.*

FDA Label Image

Chemical Structure (Buprenorphine 02)

FDA Label Image

Image (Buprenorphine 03)

FDA Label Image

Label (Lbl636299483)

This is a product description for Buprenorphine and Naloxone Sublingual Tablets, USP, containing 8.62 mg of buprenorphine hydrochloride and 2.44 mg of naloxone hydrochloride dihydrate per sublingual tablet. It can be used as a prescription medication, and it is important to keep out of reach of children. The usages and full prescribing information must be followed. The product is to be stored at a temperature between 20 to 25 C. The National Drug Code for this product is 63629-9483-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.